| Name | Title | Contact Details |
|---|
legend health staffing is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At 4Catalyzer we are transforming 21st century medicine by solving today’s most challenging problems – across life science tools, medical devices and therapeutics. We aspire to create significant societal impact and are motivated by the idea that our products will change the lives of people we love. We seek the talent of truly gifted, self-starting and driven individuals to help advance this mission. We provide a stimulating environment, surrounded by brilliant, highly committed individuals who are given both the autonomy and project ownership to solve difficult problems and be the first to publish. Each 4Catalyzer company endeavors to develop technologies that enable unprecedented looks at nature thereby affording the opportunity to do prize-winning science and publish in top-tier journals like Science and Nature. Our advisors have pioneered their fields. Our technology base includes truly novel Devices, Deep Learning and the Cloud. We understand that success requires surrounding yourself with the right people, being at the right place at the right time, and having the resources to get the job done.
Peer Review Mediation and Arbitration is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Monteris Medical is a Kalamazoo, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is currently marketing the AFX® Endovascular AAA System is available in the U.S., Europe, Latin America and other regions. The Nellix® EndoVascular Aneurysm Sealing System, a novel aneurysm sealing system, is approved for sale in Europe and other markets and for investigational use in the U.S. The Powerlink with IntuiTrak® Delivery System is available in Japan. These technologies are minimally invasive, allowing for greater patient comfort and quicker recovery compared to invasive surgical alternatives. Endologix products are protected by at least 52 U.S. patents with at least 956 allowed claims. Endologix is a publicly-held company trading on NASDAQ: ELGX. The Company`s corporate office is located in Irvine, California.